improving symptoms. Routine analysis of CSF and blood was normal. Electrocardiogram and echocardiogram were also normal.
Second Admission. Four months later, the patient presented with seizures affecting the right side of his body, and a repeat CT scan showed a new left parietal infarct adjacent to the occipital horn of the lateral ventricle ( Fig.  1) . He was started on a course of antiseizure medication (Tegretol and Dilantin). Bilateral internal carotid angiograms ( Fig. 2 ) performed at this time showed progression of the left MCA stenosis and stenosis of the A 1 segment of the left anterior cerebral artery (ACA), with increased prominence of the transthalamic and leptomeningeal collateral vessels. Severe stenosis of the right MCA and ACA with collateral vessels was also demonstrated and the diagnosis of moyamoya disease was made. No early-venous shunting was found. The patient returned 2 months later with left-sided weakness and seizures. Computerized tomography showed progressive bilateral cerebral atrophy, and the patient was started on a course of aspirin. Over the next 9 years, the seizures resolved with medical management and no further strokes occurred.
Subsequent Examination. At age 11, the patient was reevaluated for possible surgical intervention. Radionuclide brain scanning (technetium-99m hexamethylpropyleneamineoxime with single-photon emission CT) showed areas of markedly decreased or absent perfusion involving the left temporal, right frontal, and parietal lobes bilaterally. Magnetic resonance imaging showed multiple bilateral infarcts with transthalamic collateral vessels and unexpectedly prominent vascular channels in the left posterior parietal region suggesting an AVM at the level of the occipital horn (Fig. 3) , in the same region in which the previous CT showed an infarct (see Fig. 1 ). Angiography revealed bilateral internal carotid artery (ICA) occlusion above the ophthalmic arteries with transdural collateral vessels from the middle meningeal artery (Fig. 4) . The posterior cerebral arteries were also occluded with a dense network of collateral veins at the base of the brain. Extending from this collateral network, in the left parietal lobe adjacent to the occipital horn, was a wedge-shaped plexiform network of vessels shunting into the left vein of Trolard. This confirmed the diagnosis of cerebral AVM, which was not seen on the early angiograms or the early CT scans. Furthermore, the location of the AVM on both MR imaging and angiography correlated precisely with the location of the previous left parietal infarction seen on the early CT scan.
Discussion
This remarkable case documents the de novo development of a cerebral AVM in the exact location of a previous infarct in a child with moyamoya disease. No other published case of an acquired cerebral AVM is known to these authors. As cerebral infarction is common but subsequent AVM development is not, we speculate that the etiological process of vascular obstructions and collateral artery formation in moyamoya disease may have played a role in the formation of this patient's AVM.
Other authors have previously described an association of AVM and moyamoya disease. 8, 12, 13 These reports describe patients in whom the AVM was present initially, indicating that the moyamoya phenomenon was a secondary process. Indeed, in those patients who had sequential angiographic examinations, ICA obstruction and collateral vessels were shown to develop after diagnosis of the AVM. Mawad, et al., 12 hypothesized that the increased blood flow through the AVM causes turbulent flow at the carotid bifurcation leading to focal intimal hyperplasia with subsequent ICA stenosis and the development of "acquired" moyamoya phenomenon. In our case, the moyamoya disease and infarction both preceded the AVM development.
Angiogenesis is the process of new vessel formation that normally occurs during growth, healing, and fetal life, but then remains quiescent. 4 The process of angiogenesis was described by Ausprunk and Folkman 1 and involves the sprouting of capillaries, mainly from small venules. Local basement membrane degradation of the parent venule is followed by migration of endothelial cells toward the angiogenic stimulus. These endothelial cells form a solid sprout with subsequent luminization that occurs through the curving of each individual cell. Two hollow sprouts form a loop by joining at the tip and circulation can then begin. Basic fibroblast growth factor (bFGF) is a known angiogenic factor found in many cell lines, including brain and macrophages 4 as well as endothelium and smooth-muscle cells. 5, 6, 16, 21 Basic fibroblast growth factor is a powerful mitogen for fibroblasts, vascular endothelium, and smooth-muscle cells. 3, 4, 9 The exuberant collateral formation and the intimal hyperplasia found in patients with moyamoya disease suggest enhanced angiogenesis. Takahashi, et al., 20 reported significantly increased levels of bFGF in the CSF of patients with moyamoya disease, compared with patients with atherosclerotic occlusive disease. Hoshimaru, et al., 6 used immunohistochemical techniques to assay for bFGF in the STA and dura of four patients with moyamoya disease. They found intense staining in the intima and media of the STA. There was also intense staining in the meningeal and vascular cells of the dura.
The elevated levels of bFGF in these arterial tissues should be accompanied by cellular evidence of angiogenesis. Histologically, there should be migrating and proliferating target cells such as smooth-muscle cells. Masuda, et al., 11 used immunohistochemical techniques to demonstrate that the intimal hyperplasia found in intracranial lesions of six moyamoya patients was predominantly composed of smooth-muscle cells with scattered macrophages and T cells. Furthermore, the nuclear and cytoplasmic markers indicated these smooth-muscle cells were actively proliferating.
Angiogenesis is known to be stimulated by brain injury, tumor, or inflammation. 4 In a rat model of surgically induced cerebral infarction, 2 bFGF expression was increased after 1 day in the periinfarct neurons. This was followed by capillary proliferation that peaked 3 to 6 days after the infarct. Increased bFGF production was also seen
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Acquired AVM in moyamoya disease in macrophages recruited to the infarct area and in the surrounding endothelial cells and reactive glial cells. Chen, et al., 2 suggested that angiogenesis in the infarct may be initiated by neuronal derived bFGF and sustained by bFGF production from endothelial cells, macrophages, and glial cells.
Recent angiogenic studies in rat models have shown that intraventricular injection of bFGF resulted in periventricular capillary proliferation.
14 This angiogenic effect was increased when mild cerebral ischemia was induced via bilateral carotid ligation. 9 Cuevas, et al., 3 directly applied bFGF to the cerebral cortex of rats and demonstrated large-caliber vessels forming a tortuous network at the site of bFGF application. Some of these vessels extended long distances into the cerebral cortex and had disorganized, bizarre vessel architecture. New vessel sproutings included dilation, extensive capillary networking, and neovascular sprouts. Cuevas and colleagues recognized the therapeutic potential for pharmacologically induced angiogenesis to protect critically ischemic brain by inducing collateral formation. Likewise, ischemic cerebral tissue could be sustained in its recovery by such collateral vessels.
The hyperangiogenic environment of moyamoya disease in combination with the local angiogenic stimulation of cerebral infarction were unique factors in the development of this patient's AVM. We speculate that some cerebral vascular malformations can result from hyperstimulated angiogenesis. However, it remains unclear how overstimulated angiogenesis may relate to the development of typical congenital AVMs.
Conclusions
We present the first published case demonstrating an acquired AVM forming in the site of previous infarction. Little is known regarding the mechanism or process of cerebral AVM formation. We believe hyperactive angiogenesis can lead to AVM formation and may prove to be a complication in future attempts at cerebral angiogenic therapy. We hope this unique case will encourage further clinical investigation and will draw attention to a possible sequela of cerebral infarction.
